Financhill
Back

Cerevel Therapeutics Holdings Quote, Financials, Valuation and Earnings

Buy
63

CERE
Cerevel Therapeutics Holdings

Last Price:
41.33
Seasonality Move:
21.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Cerevel Therapeutics Holdings Price Quote

$41.33

Cerevel Therapeutics Holdings Key Stats

Buy
63
Cerevel Therapeutics Holdings (CERE) is a Buy

Day range:
$41.31 - $41.57
52-week range:
$19.59 - $43.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
13.34%

Volume:
731.9K
Avg. volume:
1M
1-year change:
24.9%
Market cap:
$7.5B
Revenue:
$0
EPS:
$-2.73

How Much Does Cerevel Therapeutics Holdings Make?

Data Unavailable

Is Cerevel Therapeutics Holdings Growing As A Company?

Data Unavailable

Cerevel Therapeutics Holdings Stock Price Performance

What Is Cerevel Therapeutics Holdings 52-Week High & Low?

Cerevel Therapeutics Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cerevel Therapeutics Holdings?

Is Cerevel Therapeutics Holdings Cash Flow Positive?

Cerevel Therapeutics Holdings Return On Invested Capital

Data Unavailable

Cerevel Therapeutics Holdings Earnings Date & Stock Price

Cerevel Therapeutics Holdings Competitors

Cerevel Therapeutics Holdings Dividend Yield

Data Unavailable

Cerevel Therapeutics Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -48.98%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 44.78
Upside from Last Price: 8.34%

Major Shareholders

  • How many CERE shares are owned by institutional investors?
    275.4M CERE shares are owned by institutional investors
  • How many CERE shares are owned by insiders?
    501.3K CERE shares are owned by insiders